Alba
Calvo Bacaicoa
Investigadora Colaboradora
Publicacions (10) Publicacions de Alba Calvo Bacaicoa
2024
-
Unveiling the immunomodulatory effect of the novel probiotic Akkermansia muciniphila and its protective effect in vitro
Microbiological Research, Vol. 283
2023
-
Refining Immunogenicity through Intradermal Delivery of Outer Membrane Vesicles against Shigella flexneri in Mice
International Journal of Molecular Sciences, Vol. 24, Núm. 23
2022
-
Effect of topical berberine in murine cutaneous leishmaniasis lesions
Journal of Antimicrobial Chemotherapy, Vol. 77, Núm. 4, pp. 1072-1081
-
Oral Immunogenicity of Enterotoxigenic Escherichia coli Outer Membrane Vesicles Encapsulated into Zein Nanoparticles Coated with a Gantrez® AN–Mannosamine Polymer Conjugate
Pharmaceutics, Vol. 14, Núm. 1
2021
-
Changes in the nanoparticle uptake and distribution caused by an intramacrophagic parasitic infection
Nanoscale, Vol. 13, Núm. 41, pp. 17486-17503
-
Oral Efficacy of a Diselenide Compound Loaded in Nanostructured Lipid Carriers in a Murine Model of Visceral Leishmaniasis
ACS Infectious Diseases, Vol. 7, Núm. 12, pp. 3197-3209
2020
-
Berberine-loaded liposomes for the treatment of leishmania infantum-infected balb/c mice
Pharmaceutics, Vol. 12, Núm. 9, pp. 1-18
2019
-
Evaluation of skin permeation and retention of topical dapsone in murine cutaneous leishmaniasis lesions
Pharmaceutics, Vol. 11, Núm. 11
2018
-
Combination of paromomycin plus human anti-TNF-α antibodies to control the local inflammatory response in BALB/ mice with cutaneous leishmaniasis lesions
Journal of Dermatological Science, Vol. 92, Núm. 1, pp. 78-88
2017
-
Skin vaccination using microneedles coated with a plasmid DNA cocktail encoding nucleosomal histones of Leishmania spp.
International Journal of Pharmaceutics, Vol. 533, Núm. 1, pp. 236-244